Keyphrases
Enhancer of Zeste Homolog 2 (EZH2)
100%
Endothelial Dysfunction
61%
H3K27me3
57%
Epigenetic Enzymes
50%
Cardiovascular Disease
50%
Antiatherogenic Therapy
45%
Sirtuin 1 (SIRT1)
45%
Endothelium
45%
MicroRNA-29c
45%
Epigenetic Mechanisms
45%
Endothelial-to-mesenchymal Transition (EndMT)
45%
Fibrogenesis
45%
Therapeutic Target
45%
MiR-132-3p
45%
Atherogenesis
30%
Inflammatory Activity
30%
Endothelial Cells
23%
Epigenetic Regulation
17%
Human Umbilical Vein Endothelial Cells (HUVECs)
16%
MicroRNA
15%
Pathophysiology
15%
Commercially Available
15%
Dysregulation
15%
Cardiovascular Risk
15%
Cellular Targets
15%
Lacto-N-triose II
12%
HAS3
12%
MiR-29a
12%
Long Non-coding RNA (LncRNA)
11%
Exostosin
8%
Knockdown
8%
Collagen III
8%
Collagen I
8%
Decreased Expression
8%
Regulation Network
5%
Endothelial Homeostasis
5%
Gene Expression
5%
Associated Genes
5%
Epigenetic Drugs
5%
Therapeutical Approaches
5%
Transcriptome
5%
Epigenetic Marks
5%
Clinical Development
5%
Micronome
5%
Biochemistry, Genetics and Molecular Biology
EZH2
45%
Db/Db Mouse
45%
Fibrogenesis
45%
Epigenetic Mechanism
45%
MicroRNA
45%
MiR-132
45%
Factor VII
45%
Arterial Stiffness
45%
Kruppel Like Factor
45%
Human Milk Oligosaccharide
45%
Lactobacillus plantarum
45%
Epigenetics
41%
Glypican 1
26%
HAS3
19%
Triose
19%
Gene Expression
18%
CD31
17%
Transcription Factor EZH2
13%
Tight Junction Protein 1
13%
HAS2
13%
Claudin
13%
Glycosyltransferase
13%
Glycocalyx
13%
Enzyme
13%
S100A4
11%
Transcription Factors
11%
Upregulation
11%
Transdifferentiation
6%
Genetic Marker
6%
Glycosaminoglycan
6%
Hyaluronan Synthase
6%
Intestine Flora
6%
Protein Expression
6%
Transcriptome
5%
Messenger RNA
5%
Mouse Model
5%
Prevalence
5%
Downregulation
5%
Homeostasis
5%
Immunofluorescence
5%
Mouse
5%
Quantitative Reverse Transcription Polymerase Chain Reaction
5%
Pharmacology, Toxicology and Pharmaceutical Science
Endothelial Dysfunction
68%
Cardiovascular Disease
63%
Blood Clotting Factor 7
45%
Kruppel Like Factor
45%
microRNA 132
45%
Atherogenesis
45%
microRNA
45%
Atherosclerosis
45%
Db/Db Mouse
45%
Non Insulin Dependent Diabetes Mellitus
45%
Diabetes Mellitus
34%
Transcriptome
22%
Pathophysiology
22%
Transcription Factors
11%
Cardiovascular Mortality
5%
Mouse Model
5%
Heart Infarction
5%
Disease Course
5%
Prevalence
5%
Heart Failure
5%
Mouse
5%
